Drug Executive Collapses During Oval Office Press Conference
During a press conference in the Oval Office, a drug executive fainted while President Donald Trump was announcing a new agreement with drugmakers to reduce prices on obesity medications.
Incident Details
The event was interrupted when Gordon Findlay, the global brand director for Novo Nordisk, suddenly collapsed. David Ricks, CEO of Eli Lilly, asked,
“Are you okay? Gordon, are you okay?”Mehmet Oz, the Administrator for the Centers for Medicare & Medicaid Services, quickly assisted Findlay as he fell to his knees.
Context of the Press Conference
The conference focused on a deal involving Eli Lilly and Novo Nordisk to expand coverage and lower prices for their popular obesity drugs, Zepbound and Wegovy. Health and Human Services Secretary was also present during the incident.
Aftermath
Following the collapse, the press was asked to leave the room. About 30 minutes later, the conference resumed with President Trump providing an update on Findlay's condition.
President Trump looked on as Dr. Mehmet Oz and others helped Gordon Findlay after he collapsed during the announcement on lowering drug prices.
Author’s summary: A Novo Nordisk executive fainted during a White House press conference on drug pricing, with quick assistance from Dr. Mehmet Oz and an update from President Trump shortly after.